RenovoRx, Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Net Income | $-11.2M | $-8.8M | $-10.2M | $-9.9M | $-6.3M | $-3.8M |
| Depreciation & Amortization | $2.0M | $0 | — | — | — | — |
| Depreciation | $2.0K | $0 | — | — | — | — |
| Amortization | — | — | — | — | — | — |
| Stock-Based Compensation | $1.3M | $1.2M | $1.1M | $644.0K | $147.0K | $33.0K |
| Net Cash from Operating Activities | $-11.0M | $-9.1M | $-10.3M | $-8.8M | $-5.9M | $-3.5M |
| Investing Activities | ||||||
| Capital Expenditures | $2.0K | $12.0K | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-2.0K | $-12.0K | $2.0M | $-2.0M | $-15.0K | — |
| Financing Activities | ||||||
| Dividends Paid | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — |
| Net Cash from Financing Activities | $10.8M | $15.1M | $5.0M | $42.0K | $19.3M | $3.2M |
| Net Change in Cash | $-130.0K | $6.0M | $-3.2M | $-10.8M | $13.4M | $-329.0K |
| Free Cash Flow | $-11.0M | $-9.1M | — | — | — | — |